TECON BIOLOGY Co. (002100) Fair Value & Analysis
Consumer Defensive · CN · Market cap 8.7B CNY
Fair value as of: Jul 22, 2026
From 23 valuation models · updated 19 days ago
Fair value updated Jul 22, 2026, revised from ¥3.61 to ¥3.58 (−0.8%) since Jun 25, 2026. Share price +7.3% over the past month.
A solid business, but screening 49% overvalued on our models.
What matters now
- The price sits above even our optimistic bull case (¥4.05). The favourable scenario is already priced in.
- Solid but not exceptional quality (52/100) and above fair value, neither a clear bargain nor a standout compounder.
Price vs Fair Value (5 years)
White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Jul 22, 2026.
How to read this chart
60‑month range ¥5.45 – ¥11.84 · fair‑value band ¥2.43 – ¥4.05 · the ¥7.08 price screens above the ¥3.58 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). Dashed = 300-day average. As of Jul 22, 2026.
Analysis
TECON BIOLOGY Co. (002100) currently trades at ¥7.08, while our model-based Fair Value estimate is ¥3.58, implying the stock looks roughly 49.4% overvalued today. The Quality Score stands at 52/100 (solid quality), in the Consumer Defensive sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium, the entry price still matters most (evidence: medium).
Over the trailing twelve months, TECON BIOLOGY Co. generated revenue of 16.7B CNY at a net margin of -0.6%. Revenue declined 6.3% year over year. It earns a return on equity of -0.5%. Net debt stands at 2.9B CNY. Fundamentals as of Jul 22, 2026
Our scenario range runs from ¥2.43 (bear case) to ¥4.05 (bull case); at ¥7.08, the current price sits above that range. Bear and bull are the same models run on conservative and optimistic assumptions (margins, growth, valuation multiples), so a plausible valuation range, not a price target. The share trades about 15% below its 52-week high and 18% above its 52-week low, currently below its 200-day average. For context, the median of 10 Consumer Defensive peers we cover trades at -3% fair-value upside, at -49%, 002100 screens richer than that median.
Fair Value models
Each model estimates fair value its own way; the Fair Value above is the evidence-weighted blend. Evidence (0–100) measures how completely this model’s inputs are available: well-fed models carry more weight in the blend. The spread across models is intentional, each one stresses a different value driver; dividend models, for instance, come out structurally low when payout is small.
All 23 models by family
Widest divergence: DCF Models (¥4.72) versus Growth DCF (¥0.1900). Highest evidence: Growth DCF (80).
Key figures & financial health
More key figures
Figures from reported company fundamentals · as of Jul 22, 2026. TTM = trailing twelve months.
Quality Score breakdown
Of which business quality 50 · Market factors (momentum, volatility) 49
Non-valuation factor families (profitability, growth, cashflow, financial strength, momentum …), each academically grounded. Valuation itself sits in the Fair Value and is deliberately excluded here to avoid double-counting.
About the company
TECON BIOLOGY Co.LTD, together with its subsidiaries, engages in the provision of animal health care, feed, pig breeding, agricultural product processing and trade, and financial services in China and internationally. The company offers pigs, poultry, dairy cows, ruminants, aquatic feed products, as well as premixes and additives.
Full company description
TECON BIOLOGY Co.LTD, together with its subsidiaries, engages in the provision of animal health care, feed, pig breeding, agricultural product processing and trade, and financial services in China and internationally. The company offers pigs, poultry, dairy cows, ruminants, aquatic feed products, as well as premixes and additives. The Pharmaceutical division researches and develops livestock and poultry disease vaccine products; and cottonseed meal and oils, cotton hull, and short plush, as well as engages in pig genetics and breeding; commercial pig breeding and fattening; feeding technology research and development; pig slaughtering and processing; meat processing; and cold chain distribution and sales. It is also involved in the purchase and sale of agricultural and sideline products; drying, storage, and logistics of agricultural crops; agricultural machinery provision; processing of grain storage equipment; import and export of goods and technology; railway freight forwarding; road freight transport; container transport services provision; production, processing, sales, and agency activity of agricultural materials, etc. The company was formerly known as Xinjiang Tecon Animal Husbandry Bio-Technology Co., Ltd. and changed its name to Tecon Biology Co.Ltd in June 2016. Tecon Biology Co.Ltd was founded in 1993 and is headquartered in Urumqi, China.
Company description, as reported by the company or data provider.
Revenue & earnings trend
FY2021 – FY2025 · reported fiscal years
TECON BIOLOGY Co. reported revenue of ¥17.0B in FY2025 versus ¥15.7B in FY2021, a compound +2.0%/yr. Reported net income was ¥211M in FY2025.
002100 screens 49% overvalued. Compare with Nestlé India Limited →
Peer Group
Packaged Foods · 653 stocks
How this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.
Valuation Multiples vs Packaged Foods median · lower = cheaper
Snowflake
Five quick dimensions, each 0 to 100: VALUE (fair-value potential), FUTURE (revenue growth), PAST (return on equity), HEALTH (low debt), DIVIDEND (yield). Green = this stock, grey = typical sector peer.
VALUE 0: the price sits above our fair-value range.
Values & ESG
Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.
ESG scores are not available for this stock yet. Values and ESG data are contextual and can differ between providers.
Similar stocks
10 more Packaged Foods stocks, each showing price versus our Fair Value estimate (as of Jul 22, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| Nestlé India Limited NESTLEIND | ₹1,427 | ₹362.37 | -75% |
| Britannia Industries Limited BRITANNIA | ₹5,413 | ₹1,870 | -65% |
| Tata Consumer Products Limited TATACONSUM | ₹1,089 | ₹327.27 | -70% |
| PT Indofood CBP Sukses Makmur Tbk ICBP | 6,650 IDR | 15,757 IDR | +137% |
| Samyang Foods Co 003230 | 1,139,000 KRW | 1,010,543 KRW | -11% |
| Patanjali Foods Limited PATANJALI | ₹413.80 | ₹157.04 | -62% |
| Vietnam Dairy Products Joint Stock Company VNM | 58,500 VND | 68,259 VND | +17% |
| PT Mayora Indah Tbk, MYOR | 1,750 IDR | 2,699 IDR | +54% |
| PT Cisarua Mountain Dairy Tbk CMRY | 4,490 IDR | 4,355 IDR | -3% |
| Nongshim Co 004370 | 348,500 KRW | 530,619 KRW | +52% |
Compare TECON BIOLOGY Co. with another stock
Price, fair value, quality and upside side by side.
Explore undervalued stocks
More undervalued Consumer Defensive stocks →
Frequently asked questions
Is TECON BIOLOGY Co. (002100) overvalued or undervalued?
What is the fair value of 002100?
What is the quality score of 002100?
What is the revenue of TECON BIOLOGY Co. (002100)?
What is the net profit margin of 002100?
Does TECON BIOLOGY Co. pay a dividend?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data, nothing guessed.
Track TECON BIOLOGY Co. and try Pro for 14 days
One email gets you 14 days of full Pro (review alerts, the 35,000+ stock screener, the diversification check) plus the monthly Top-25 report of the most undervalued quality stocks. No card, cancel anytime.
Zero risk: nothing is ever charged. After 14 days you decide whether to stay.